PDL1-binding peptide/anti-miRNA21 conjugate as a therapeutic modality for PD-L1high tumors and TAMs.
Kim EH, Lee J, Kwak G, Jang H, Kim H, Cho H, Jang Y, Choi J, Chi SG, Kim K, Kwon IC, Yang Y, Kim SH.
Kim EH, et al. Among authors: jang h, jang y.
J Control Release. 2022 May;345:62-74. doi: 10.1016/j.jconrel.2022.02.031. Epub 2022 Mar 6.
J Control Release. 2022.
PMID: 35263615